Surgical morbidity in retroperitoneal sarcoma resection.
Andrea J MacNeill, Marco Fiore
https://pubmed.ncbi.nlm.nih.gov/29314041/Actively Recruiting
Led by Heidelberg University · Updated on 2026-07-23
120
Participants Needed
16
Research Sites
18 weeks
Total Duration
Researchers are examining colorectal resections and reconstruction techniques in patients undergoing multivisceral surgery for retroperitoneal sarcomas. This multicenter observational study aims to assess surgical methods, complications related to intestinal surgery such as anastomotic leakage, and how these affect patients quality of life. The study focuses on patients who had colon resection as part of their sarcoma surgery and intends to improve surgical decision-making and patient outcomes. The study includes approximately 120 patients treated at certified sarcoma centers or equivalent hospitals. It documents surgical techniques used during multivisceral resections involving the colon and rectum. Data collected includes the frequency of primary anastomoses, rates of anastomotic leakage, and the incidence of primary and secondary stomas. Quality of life and bowel function are assessed through standardized questionnaires and interviews, capturing patient experiences and specific challenges related to surgery and recovery. Participants are followed from surgery through about one year post-operation. Researchers evaluate surgical details immediately after surgery and monitor complications for up to 90 days. Quality of life and bowel function are assessed throughout the study. Patient, tumor, and treatment-related factors are analyzed to understand their influence on outcomes. The study collects patient surveys and conducts interviews to identify unmet needs, aiming to support better preoperative and intraoperative decisions in future care.
CONDITIONS
Colorectal Resections in Patients With Retroperitoneal Sarcoma
J
Jens Jakob, Prof.
M
Madelaine Hettler, Dr.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Heidelberg University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - About 1 year
Participants provide surgical and treatment information and complete quality of life and bowel function questionnaires. Some may participate in interviews about their experiences and challenges after surgery.
Regular assessments during the study period
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Andrea J MacNeill, Marco Fiore
https://pubmed.ncbi.nlm.nih.gov/29314041/Madelaine Hettler, Katrin R Scharpf, Anna Eich...
https://pubmed.ncbi.nlm.nih.gov/41469069/Jens Jakob, Leopold Hentschel, Stephan Richter...
https://pubmed.ncbi.nlm.nih.gov/35700716/Syvie Bonvalot, Chandrajit P Raut, Raphael E Pollock...
https://pubmed.ncbi.nlm.nih.gov/22476756/Alessandro Gronchi, Dirk C Strauss, Rosalba Miceli...
https://pubmed.ncbi.nlm.nih.gov/26727100/Heidelberg University
Lead Sponsor